Member Info for Trendz

Surprised to see the SP down here but I see 100 % upside in the next 12 months. Good business and profitable without fundraising needs

Big old shake out yesterday. Wouldn't surprise me to see this back above £4 tomorrow. Such a bargain.

Hello gents. Been following the NCYT debacle. I originally bought in back at 300 and sold out around 800. The share price is now too low and looks very attractive.

But commercialisation roll out not for another few weeks... From what I’m hearing, the Gov have ordered far far too many Covid tests and are desperately trying to off load them / cancel contracts... good work from Avacta but I want to see contracts and values before investing here. Otherwise, this is still a big punt. I’ll be very surprised if the SP ‘goes to the moon’! today and in fact there could be a bit of sell the news type action...

Oh yes agreed. No doubt Avacta will sell millions of tests... but quite clearly governments and companies can’t afford to stump up for Covid testing month on month after the pandemic ends... testing at significant levels will be around for the rest of this year but the vaccines will ultimately stop this pandemic. The question then becomes, how much can Avacta milk from the cow. I’m personally waiting to see the size of the U.K. gov order to gauge this.. as the market cap, IN MY OPINION, is already factoring in some huge revenue..

And fwiw I wouldn’t worry about the specific timing of the commercial launch and certifications... so long as it arrives in the next couple of weeks, Avacta should be able to secure 2021 contracts... the specificity looks very very good and much better than other current LFTs.

Why is the board so loathe to discuss the potential downsides? I always love to play devil’s advocate with all my shares, as it keeps you balanced. Avacta is really interesting... but I’m sceptical as to whether mass testing is sustainable to justify Avactas market cap. That’s all. Waiting to see the size of the government order personally but GL to all in now.

With the government not mandating LFT and rather offering them for free twice weekly, with the stipulation you self register the results and self isolate, will the U.K. population take up the offer? I personally won’t but interested to hear views. Also, looks like these pilot mass gatherings are being without testing...

But I have been very skeptical of Avacta's high market cap given the Covid-19 pandemic is progressing towards an end.

However, I have changed my mind after doing more research into testing requirements. As an example, this is from the IC this morning:

"Moreover, the wider vaccine roll-out is racing against the reopening of the economy. That is before mentioning the slower rate of inoculation overseas. As tourism picks up again, the probability of importing Covid-19 cases from abroad will only increase. The same goes for virus variants.

Diagnostics will thus remain a vital weapon in Downing Street’s arsenal. Covid-19 tests have ramped up in the UK from zero last spring to 1.2m a day. And as ‘stay at home’ mandates ease, testing will only become more important – in turn drawing greater levels of investment.

Authorities are already working with schools, employers and staff to trace the virus and break chains of transmission as lockdown ends. Everyone in England, including those without symptoms, can now take a free rapid coronavirus test twice a week. Businesses including the Financial Times Group are asking staff to test regularly before entering the workplace."

My concerns for Avacta lie in being able to roll the LFT out quickly enough (certifications, production, distribution etc...) to take advantage of the market opportunity. However, it is now clearer to me that highly accurate LFT tests are going to be the 'go-to' test.

Currently considering entering Avacta...

Please can someone educate me as to the possible / likely timescales for actually generating revenue from its LFT?

P.S. less abuse on here please. People can switch from sellers to buyers and visa-versa without the need for wild outrage. Its healthy to look at both sides of the argument and also be flexible with your views (even if they are/were strong)...

And Uber!

Also - do people realise how good the dark kitchens model is? It’s hugely disruptive to the takeaway restaurant business and is massive plus for ROO. Plus the ease of getting grocery deliveries at the click of a button on the app, without needing to log onto a supermarkets own website/app WILL change behaviours. I use Deliveroo for a monthly fee and just order all my booze, takeaways and groceries on it... the idea of having your own dedicate delivery business for everything is a seriously underpenetrated market. For me, it’s an essential service, together with Amazon, Apple, Microsoft...

Posted some incredible Q1 figures today... explains the rise here. I think this will settle around £3. Lots of people taking extreme views. For example, saying this will become the next Amazon... saying the company is worthless and going to a quid. The truth is that the IPO was overpriced but my fair value price is £3 - £3.20. This is based on my own research. DYOR and take your positions...

If quantumscape can fetch a 17b valuation, I’m pretty sure ilika will make it to a billion sometime in the next 12 months or so

JE is valued at £10.75B with £2B revenue and £147m loss for 2020. Roo is valued at £4.35B with £1.2B revenue and a £220m loss for 2020. One can probably argue that Roo is growing faster than Just Eat, and so I think the recent sell off is overdone. Using the JE valuation metric of 5.375 times revenue, one can argue that Roo should be valued at £6.45B plus (25 percent upside) - almost back up at its IPO price. I personally think that Deliveroo is much better the Just Eat based on its dark kitchens offering. It’s also earlier in its company lifecycle and has better growth prospects that JE. Trading update will be very interesting.

Q1 trading update on weds... a bit embarrassed by this but I took the £1000 retail IPO offer and then doubled down on Friday at 270... having not read the admission document! I did it purely based on loving Deliveroo as a customer and wanting to be part of its journey... my question is, how much was stated about Q1 trading in the admission doc? We could be in for a strong update? Perhaps stabilise the catastrophic IPO mess? The greedy bastard banks have screwed the company's customers and new investors here. Greed is powerful. Personally, I feel that Deliveroo will fight back but it will take a year or so to get back to £3.90 plus... happy to stay invested for 5-10 years here.

Morning guys - I’ve heard through the grapevine that Gfinity has engaged Twilio (£61b market cap) to assist with major ramp of monetisation efforts... I feel that Gfin could seriously blow the doors off at some point.

My flat is listed for sale in London and I had a chat with our estate agent (acorn group - so, a big boy) re online property portfolios. The message was that OTMP is very very good and they absolutely need it. Interestingly, they said that the more platforms they can advertise properties on, the better, as sourcing of viewings is increasingly shifting online rather than ‘In store’. OTMP was described as providing better quality buyers than zoopla! I was so impressed, I doubled my holdings here. Struggling to see why the share price has fallen 30-40 percent here but for a growing company, now becoming profitable, with strong thematic tailwinds (move to online and a buoyant property market, which the government supports at all costs) my 12 months market cap target is £120m, which assumes 20 percent revenue growth in 2021. It could, and probably should, be a lot higher than this given the monstrous valuation gap with Rightmove (which is valued in a different universe). GLA

Ok - if Avacta totally binned it’s Covid testing plans, what would the market cap be? Answer - at least 75% lower

Avacta is valued far higher than Novacyt which has over a year of sales to governments and organisations all over the world, there NEEDS to be some pretty gargantuan RNS soon, whilst this short window of mass testing lasts

higher in value that Novacyt. Discuss.